Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Craftport Cannabis Corp Com C.BBT


Primary Symbol: BHHKF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
Benchmark Botanics Inc through its subsidiaries, operates as a producer of medical cannabis. The company provides financing, partnership opportunities and acquisition offers to licensed producers and ancillary businesses within the cannabis industry. It operates approximately 12,000 square foot production facility in Peachland, British Columbia.


OTCPK:BHHKF - Post by User

Craftport Cannabis Corp Com
Bullboard Posts
User Avatar Image
(27)
•••
Comment by STOCKRUSon May 22, 2019 8:50am
17 Views
Post# 29763167

RE:Strong, honorable Leadership! Stronger BBT stock price!

RE:Strong, honorable Leadership! Stronger BBT stock price!Yes William Ying CEO has done a good job esp. with bringing in the China-based Zhejiang Yatai Pharmaceutical Co. Ltd., to promote and conduct research and development, production, extraction, and the commercial application of CBD and its derivative products for medical applications.

Benchmark and Zhejiang Yatai agree to create, develop and market a variety of high-content, CBD-based pharmaceuticals, natural health products and cosmetics for international markets.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities